What are the Australian guidelines for managing an adult with a soft‑tissue infection (cellulitis), including wound care and antibiotic selection?

Australian Guidelines for Managing Adult Cellulitis

For uncomplicated cellulitis in Australian adults, use narrow-spectrum β-lactam antibiotics—specifically flucloxacillin or cefazolin—as first-line therapy, combined with wound care addressing local risk factors including edema, venous disease, and skin barrier integrity.

Antibiotic Selection

First-Line Therapy

The most appropriate empiric antibiotics for uncomplicated cellulitis in Australia are:

• Flucloxacillin (oral or IV depending on severity)
• Cefazolin (IV for hospitalized patients)
• Cefalexin (oral for outpatient management)
• Dicloxacillin (oral alternative)

Recent data from tropical Queensland confirms that the microbiology of cellulitis in Australia mirrors temperate regions, with Staphylococcus aureus (48%) and Group A Streptococcus (17%) as the predominant pathogens 1. This validates the use of narrow-spectrum β-lactams as standard therapy across all Australian regions 1.

In a 2019-2020 Australian study, flucloxacillin was prescribed in 56% of cases and cefazolin in 26%, representing evidence-based practice 1. These narrow-spectrum agents provide appropriate Gram-positive coverage for mild-to-moderate skin and soft tissue infections 2.

When to Broaden Coverage

Reserve broad-spectrum antibiotics for specific high-risk scenarios:

• Necrotizing infections or systemic toxicity: Use vancomycin or linezolid PLUS piperacillin-tazobactam, or PLUS a carbapenem, or PLUS ceftriaxone and metronidazole 3
• Polymicrobial infections (post-surgical, diabetic foot): Consider amoxicillin-clavulanate 2
• MRSA suspected: Add vancomycin or linezolid to regimen

Severity Assessment and Triage

Use Early Warning Scores (EWS)

An EWS ≥3 on admission is critical for risk stratification 1:

• Every patient who died or required ICU admission had EWS ≥3
• Predicts prolonged hospital stay >48 hours (OR 3.2)
• Predicts 30-day readmission (OR 2.3)

Clinical Criteria for Antibiotic Necessity

Antibiotics are NOT required if ALL of the following are present 3:

• Erythema <5 cm
• Temperature <38.5°C
• WBC <12,000 cells/µL
• Heart rate <100 beats/minute

Short-course antibiotics (24-48 hours) are indicated when 3:

• Temperature >38.5°C OR
• Heart rate >110 beats/minute OR
• Erythema extending >5 cm beyond wound margins

Wound Care and Non-Pharmacological Management

Address Local Risk Factors

Recent systematic reviews emphasize that guidelines inadequately address non-pharmacological prevention 4. Critical interventions include:

• Edema management: Compression therapy, elevation
• Venous disease treatment: Address underlying venous insufficiency
• Tinea pedis eradication: Treat interdigital fungal infections
• Skin barrier integrity: Emollients, treatment of xerosis and fissures
• Obesity management: Weight reduction counseling

Wound Care Principles

For surgical site infections or wounds with purulent drainage 3:

• Primary intervention is incision and drainage
• Continue dressing changes until healing by secondary intention
• Antibiotics are adjunctive, not primary therapy
• Prophylactic antibiotics NOT recommended for simple abscess drainage

Treatment Duration

Shorter antibiotic courses are increasingly recommended 5. While specific durations vary by severity:

• Uncomplicated cellulitis: 5-7 days typically sufficient
• Adjust based on clinical response, not arbitrary duration
• De-escalate from IV to oral when clinically improving

Common Pitfalls to Avoid

1. Over-prescribing broad-spectrum antibiotics: Australian data shows 78-82% appropriate prescribing at baseline, but unnecessary vancomycin and broad-spectrum use remains problematic 6

2. Ignoring recurrence prevention: 21% of patients are readmitted within 30 days 1. Address underlying risk factors, not just acute infection

3. Treating colonization as infection: Not all positive cultures require antibiotics—clinical signs of infection must be present

4. Neglecting surgical consultation: Obtain urgent surgical evaluation for any signs of necrotizing infection, systemic toxicity, or gas in tissues 3

5. Inadequate severity assessment: Use objective criteria (EWS, vital signs) rather than subjective impression alone 1

Implementation Challenges

Despite evidence-based guidelines, an Australian implementation study found only 29% uptake of a cellulitis management plan, with no significant improvement in prescribing appropriateness (78.7% to 81.8%) 6. Active stewardship programs and decision-support tools are essential to translate guidelines into practice 5.